# PD-L1 Expression in Cancer (PECan Study).

> **NCT04436406** · NA · UNKNOWN · sponsor: **Guy's and St Thomas' NHS Foundation Trust** · enrollment: 30 (estimated)

## Conditions studied

- Non-small Cell Lung Cancer
- Melanoma

## Interventions

- **DIAGNOSTIC_TEST:** [99mTc]-NM-01 SPECT/CT

## Key facts

- **NCT ID:** NCT04436406
- **Lead sponsor:** Guy's and St Thomas' NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03-11
- **Primary completion:** 2023-10-31
- **Final completion:** 2024-01-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2022-12-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04436406

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04436406, "PD-L1 Expression in Cancer (PECan Study).". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04436406. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*